STELLANT DUAL CT INJECTOR 58746456 SCT D

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-02-12 for STELLANT DUAL CT INJECTOR 58746456 SCT D manufactured by Bayer Medical Care Inc..

Event Text Entries

[188648061] A system service check of the stellant ct injector, serial number (b)(4), was completed on january 29, 2020 which confirmed that the injector was operating within bayer specifications. There was no evidence of equipment malfunction. The stellant disposable set that was in use during the procedure was discarded by the site; however, the lot number that was in use during the time of the incident was provided. Bayer product analysis tested a retained sample from sds-ctp-qft, lot number 8572269. No visual or functional defects were identified. Functional testing concluded that the retained disposables performed to specification with no problems observed. Additional applications training was offered; however, the site declined. The site continues to use the stellant ct injection system after the reported event with no further issues reported.
Patient Sequence No: 1, Text Type: N, H10


[188648062] Bayer medical care was notified of an extravasation that occurred during an enhanced ct scan of the abdomen and pelvis while a patient was connected to a stellant ct injection system. The customer reported that an undisclosed amount of contrast extravasated in the patient's right antecubital space during the injection. Approximately 3 hours after the exam was completed, the patient called the facility to report that their right arm was swollen and painful. The facility staff referred the patient to their physician and at the time of the call recommended applying an icepack and elevating the affected extremity. The patient was re-evaluated the following day at their scheduled urology follow-up appointment and, while on site, the physician examined the extremity and noted the presence of normal pulses and mild induration with no evidence of tissue damage. No further medical intervention was necessary.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2520313-2020-00004
MDR Report Key9701368
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-02-12
Date of Report2020-02-12
Date of Event2020-01-27
Date Mfgr Received2020-01-28
Device Manufacturer Date2003-09-22
Date Added to Maude2020-02-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDIANE ECKERT
Manufacturer Street1 BAYER DRIVE
Manufacturer CityINDIANOLA PA 15051
Manufacturer CountryUS
Manufacturer Postal15051
Manufacturer Phone7249408677
Manufacturer G1BAYER MEDICAL CARE INC.
Manufacturer Street1 BAYER DRIVE
Manufacturer CityINDIANOLA PA 15051
Manufacturer CountryUS
Manufacturer Postal Code15051
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTELLANT DUAL CT INJECTOR
Generic NameCT INJECTION SYSTEM
Product CodeDXT
Date Received2020-02-12
Model Number58746456
Catalog NumberSCT D
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBAYER MEDICAL CARE INC.
Manufacturer Address1 BAYER DRIVE INDIANOLA PA 15051 US 15051


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-02-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.